指南与共识腹部技术与安全USCTMR

第1部分:CAR代谢功能障碍相关脂肪性肝病工作组关于使用超声、CT或MRI检测和分级肝脂肪变的指导声明

Part 1: CAR Metabolic Dysfunction-Associated Steatotic Liver Disease Working Group Guidance Statements for Detecting and Grading Hepatic Steatosis Using Ultrasound, CT, or MRI.
指南 / 共识 · Can Assoc Radiol J · 2025-08-05

加拿大放射科医师协会(CAR)代谢功能障碍相关脂肪性肝病(MASLD)工作组由放射科、肝病科和家庭医生组成,通过Delphi共识制定3部分系列指南;第1部分针对超声、CT或MRI检测、分级和监测肝脂肪变给出17条指导声明,并评述半定量与定量超声技术的适应证与推荐技术。

要点

  • MASLD即原非酒精性脂肪性肝病(NAFLD),本部分聚焦超声、CT或MRI对肝脂肪变的检测与分级。
  • 除常规B型超声外,工作组评述了半定量和定量超声技术的现有证据并给出适应证与技术推荐。
  • 系列第1部分共给出17条指导声明,涉及肝脂肪变的检测、分级和监测三条主线。

核心结论

  • CAR MASLD工作组通过Delphi共识制定3部分系列指南,第1部分就超声、CT或MRI检测、分级和监测肝脂肪变给出17条指导声明。

研究设计与样本

  • 加拿大放射科医师协会(CAR)MASLD工作组为多学科工作组,由放射科医师、肝病科医师和家庭医生组成,采用Delphi共识制定指导声明。

诊断标准与关键数值

  • 第1部分给出的17条指导声明针对使用超声、CT或MRI对肝脂肪变进行检测、分级和监测。
  • 除常规B型超声外,工作组评述半定量和定量超声技术的现有证据,并就适应证和推荐技术给出指导。

临床应用与阅片要点

  • 本系列第1部分用于指导已知或疑似MASLD患者肝脂肪变的影像检测与分级,第2部分涉及风险分层与患者路径,第3部分涉及SWE和MRE质量保证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

The Canadian Association of Radiologists (CAR) metabolic dysfunction-associated steatotic liver disease (MASLD) Working Group (WG) is a multidisciplinary working group composed of radiologists, hepatologists, and family physicians. In this 3-part series, we provide Delphi consensus-based guidance on clinical and imaging findings for patients with known or suspected MASLD (formerly termed non-alcoholic fatty liver disease or NAFLD). Part 1 focuses on the detection and grading of hepatic steatosis on imaging; Part 2 on risk-stratification of patients with MASLD, including a patient pathway that incorporates serological and imaging investigations; and Part 3 on the implementation of practice recommendations for quality assurance using shear wave elastography (SWE) and magnetic resonance elastography (MRE) for disease staging. In the first part of these guidelines, we provide 17 guidance statements for detection, grading, and surveillance of hepatic steatosis using ultrasound (US), CT, or MRI. In addition to conventional B-mode US, we review current evidence on semi-quantitative and quantitative US techniques and provide guidance for appropriate indications and recommended technique.

来源:Can Assoc Radiol J,查看原文。版权归原作者所有。

引用

  1. Wilson MP, Tang A, Low G, et al. Part 1: CAR Metabolic Dysfunction-Associated Steatotic Liver Disease Working Group Guidance Statements for Detecting and Grading Hepatic Steatosis Using Ultrasound, CT, or MRI. Can Assoc Radiol J. 2025. PMID: 40765159. doi:10.1177/08465371251357444

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。